Trademark: 88280916
Status Date
Wednesday, November 6, 2019
Filing Date
Tuesday, January 29, 2019
Abandoned Date
Thursday, October 24, 2019
5 Pharmaceuticals and pharmaceutical products for treating friedreich's ataxia, huntington's disease, myotonic dystrophy, spinocerebellal ataxia, fragile-x syndrome and other neuromuscular, metabolic, autoimmune, cardiovascular, hyperplastic diseases that respond to ribonucleic acid (RNA)-based therapies; pharmaceuticals comprising drugs based on oligonucleotides and drugs that modulate RNA expression
The wording "Ittero" has no meaning in a foreign language.
Nov 6, 2019
Abandonment Notice E-Mailed - Failure To Respond
Nov 6, 2019
Abandonment - Failure To Respond Or Late Response
Apr 23, 2019
Notification Of Non-Final Action E-Mailed
Apr 23, 2019
Non-Final Action E-Mailed
Apr 23, 2019
Non-Final Action Written
Apr 10, 2019
Assigned To Examiner
Feb 21, 2019
New Application Office Supplied Data Entered In Tram
Feb 1, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24